Literature DB >> 19140189

Incidence of hepatitis B reactivation following Rituximab therapy.

Amr Hanbali1, Yasser Khaled.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19140189     DOI： 10.1002/ajh.21343

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  10 in total

Review 1.  Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy.

Authors:  Pilar López-Serrano; Elsa de la Fuente Briongos; Elisa Carrera Alonso; Jose Lázaro Pérez-Calle; Conrado Fernández Rodríguez
Journal:  World J Hepatol       Date:  2015-03-27

2.  Lymphoproliferative disease-related mixed cryoglobulinemia treated with rituximab and prednisolone.

Authors:  Yoshinosuke Shimamura; Hideki Takizawa; Yayoi Ogawa; Hajime Sakai; Akane Ryu; Norihito Moniwa; Koichi Hasegawa; Nobuyuki Ura
Journal:  CEN Case Rep       Date:  2014-08-27

3.  Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens.

Authors:  John-Paul Westwood; Mari Thomas; Ferras Alwan; Vickie McDonald; Sylvia Benjamin; William A Lester; Gillian C Lowe; Tina Dutt; Quentin A Hill; Marie Scully
Journal:  Blood Adv       Date:  2017-06-26

4.  Progressive multifocal leukoencephalopathy following treatment with bendamustine and rituximab.

Authors:  Sean Warsch; Peter J Hosein; Michele I Morris; Uygar Teomete; Ronald Benveniste; Jennifer R Chapman; Izidore S Lossos
Journal:  Int J Hematol       Date:  2012-06-09       Impact factor: 2.490

Review 5.  Hepatitis B reactivation and rituximab in the oncology practice.

Authors:  Jeryl Villadolid; Kourtney D Laplant; Merry Jennifer Markham; David R Nelson; Thomas J George
Journal:  Oncologist       Date:  2010-10-07

Review 6.  Hepatitis B and inflammatory bowel disease: role of antiviral prophylaxis.

Authors:  Pilar López-Serrano; Jose Lázaro Pérez-Calle; Maria Dolores Sánchez-Tembleque
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

Review 7.  Clinical impact of occult hepatitis B virus infection in immunosuppressed patients.

Authors:  Evangelista Sagnelli; Mariantonietta Pisaturo; Salvatore Martini; Pietro Filippini; Caterina Sagnelli; Nicola Coppola
Journal:  World J Hepatol       Date:  2014-06-27

8.  Safety and efficacy of rituximab treatment for vasculitis in hepatitis B virus-associated type II cryoglobulinemia: a case report.

Authors:  Florian Pasquet; François Combarnous; Brigitte Macgregor; Brigitte Coppere; Christelle Mausservey; Jacques Ninet; Arnaud Hot
Journal:  J Med Case Rep       Date:  2012-01-27

Review 9.  Understanding the Cryoglobulinemias.

Authors:  Alejandro Fuentes; Claudia Mardones; Paula I Burgos
Journal:  Curr Rheumatol Rep       Date:  2019-11-19       Impact factor: 4.686

Review 10.  Hepatitis B Virus-Related Cryoglobulinemic Vasculitis: Review of the Literature and Long-Term Follow-Up Analysis of 18 Patients Treated with Nucleos(t)ide Analogues from the Italian Study Group of Cryoglobulinemia (GISC).

Authors:  Cesare Mazzaro; Luigino Dal Maso; Laura Gragnani; Marcella Visentini; Francesco Saccardo; Davide Filippini; Pietro Andreone; Anna Linda Zignego; Valter Gattei; Giuseppe Monti; Massimo Galli; Luca Quartuccio
Journal:  Viruses       Date:  2021-05-30       Impact factor: 5.048
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.